Abstract
Conclusions:Our work here showed that patients with schizophrenia, treated with AOM in everyday clinical conditions, may experience clinically relevant functional improvements. These data add support to the body of evidence demonstrating the robust effectiveness of AOM in schizophrenia.
Oluboka, O., Clerzius, G., Janetzky, W. et al. Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study). BMC Psychiatry 23, 383 (2023). https://doi.org/10.1186/s12888-023-04893-8